DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
Conditions:   Prostate Cancer;   Kidney Cancer;   Congenital Abnormality of Kidney;   Nephrolithiasis;   Kidney Tuberculosis;   Nephritis;   Kidney Injury;   Hydronephrosis Intervention:   Sponsor:   Aesculap AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2021 Category: Research Source Type: clinical trials

Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects
Conditions:   Tuberculosis;   Tuberculosis, Pulmonary Interventions:   Drug: 1800 mg TBI-223;   Drug: 2400mg TBI-223;   Drug: 3000mg TBI-223;   Drug: TBI-223 Placebo Sponsor:   Global Alliance for TB Drug Development Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Effect of Smoking Cessation on Tuberculosis Treatment Outcomes
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Bupropion;   Behavioral: Behavioural Change Communication Sponsor:   Dow University of Health Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2021 Category: Research Source Type: clinical trials